• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs.

作者信息

De Caterina Raffaele, Mundi Santa, Fusaro Maria

机构信息

Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa; and Fondazione VillaSerena per la Ricerca, Città Sant'Angelo, Pescara, Italy.

National Research Council (CNR) Institute of Clinical Physiology, Lecce, Italy and Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA), University of Salento, Lecce, Italy.

出版信息

Eur Heart J. 2020 Mar 7;41(10):1109-1111. doi: 10.1093/eurheartj/ehaa077.

DOI:10.1093/eurheartj/ehaa077
PMID:32083296
Abstract
摘要

相似文献

1
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs.维生素K拮抗剂与骨质疏松性骨折：与新型口服抗凝药比较的见解
Eur Heart J. 2020 Mar 7;41(10):1109-1111. doi: 10.1093/eurheartj/ehaa077.
2
Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.骨质疏松性骨折在接受常规抗凝剂与直接抗凝剂治疗的心房颤动患者中的比较。
J Am Coll Cardiol. 2019 Oct 29;74(17):2150-2158. doi: 10.1016/j.jacc.2019.08.1025.
3
[Anticoagulant and bone fragility: which implications for clinical practice?].
Rev Med Suisse. 2021 Apr 21;17(735):766-769.
4
Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists.心房颤动的死亡率：阿司匹林、维生素 K 和非维生素 K 拮抗剂的作用。
Int J Clin Pharm. 2019 Dec;41(6):1536-1544. doi: 10.1007/s11096-019-00916-1. Epub 2019 Oct 8.
5
Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.非维生素K拮抗剂口服抗凝剂用于非瓣膜性心房颤动患者的疗效和安全性比较
Semin Thromb Hemost. 2015 Mar;41(2):146-53. doi: 10.1055/s-0035-1544156. Epub 2015 Feb 15.
6
Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.维生素K与非维生素K拮抗剂口服抗凝药用于非瓣膜性心房颤动的真实世界研究
Eur J Intern Med. 2016 Sep;33:42-6. doi: 10.1016/j.ejim.2016.06.022. Epub 2016 Jul 6.
7
Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.房颤患者使用维生素K拮抗剂、非维生素K拮抗剂口服抗凝药和阿司匹林相关的大出血和中风风险：一项队列研究
Br J Clin Pharmacol. 2017 Aug;83(8):1844-1859. doi: 10.1111/bcp.13265. Epub 2017 Mar 24.
8
Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.非维生素K拮抗剂口服抗凝药用于心房颤动
Hematol Oncol Clin North Am. 2016 Oct;30(5):1019-34. doi: 10.1016/j.hoc.2016.05.002.
9
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.新型口服抗凝剂在心房颤动中的疗效和安全性：文献的系统评价和荟萃分析。
Circulation. 2012 Nov 13;126(20):2381-91. doi: 10.1161/CIRCULATIONAHA.112.115410. Epub 2012 Oct 15.
10
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.新型口服抗凝药与华法林在非瓣膜性心房颤动初治患者中的疗效和安全性比较：倾向评分匹配队列研究。
Int J Cardiol. 2017 Dec 15;249:198-203. doi: 10.1016/j.ijcard.2017.09.029. Epub 2017 Sep 18.

引用本文的文献

1
Effect of antiplatelet and anticoagulant medications on implant survival: a long-term retrospective cohort study.抗血小板和抗凝药物对植入物存活的影响：一项长期回顾性队列研究。
Oral Maxillofac Surg. 2025 Jan 23;29(1):43. doi: 10.1007/s10006-025-01341-7.
2
Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta-Analysis.不同口服抗凝药物治疗患者的骨折风险：系统评价和荟萃分析。
J Am Heart Assoc. 2021 Apr 6;10(7):e019618. doi: 10.1161/JAHA.120.019618. Epub 2021 Mar 24.